Factors Contributing to Exacerbating Vulnerabilities in Global Clinical Trials

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2017.00999
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Pcn29 - Contributing Factors to Lower Effectiveness of Oncology Drugs Compared to Their Efficacy in Clinical Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Role of Racial/Ethnic Factors in Global Clinical Trials

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2018English

Factors Influencing Physician Referrals of Patients to Clinical Trials

Journal of the National Medical Association
Medicine
2008English

Factors Contributing to Racial Disparities in Influenza Vaccinations

PLoS ONE
Multidisciplinary
2019English

Identification of Factors Contributing to T-Cell Toxicity of Staphylococcus Aureus Clinical Isolates

Journal of Clinical Microbiology
Microbiology
2008English

Did Randomized Clinical Trials (RCT) and Continually Are Contributing Evidence for Progress in Radiation Oncology

Journal of Head Neck & Spine Surgery
2018English

Factors Contributing to Enrollment in Treatment Programs for Adults

2012English

Academic Procrastination and Factors Contributing to Its Overcoming

New Educational Review
Education
2015English

Factors Contributing to Safe Appendectomy in Presence of Appendiceal Mass

Janaki Medical College Journal of Medical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy